Jul 11, 2019 / 07:30AM GMT
Operator
Hello and welcome to the BioArctic Q2 2019 report.(Operator Instructions) Just to remind you, this conference call is being recorded. Today, I am pleased to present CEO, Gunilla Osswald and CFO, Jan Mattsson. Please go ahead with your meeting.
Gunilla Osswald - BioArctic AB(publ)-CEO
Thank you so much. And most welcome to the BioArctic interim report for the first half of 2019. I'm Gunilla Osswald, and I'm the CEO of BioArctic. And I will share the presentation here today with our CFO, Jan Mattsson.
Next slide, please. BioArctic is listed on Nasdaq Stockholm mid-cap stock market, and this is our disclaimer.
Next slide, please. So today, I will start with a summary of our significant projects -- progress that we have had in all our areas during the first half of this year. Last year was a fantastic year for BioArctic, and this first half of this year has continued to show great progress in all 3 disease areas as well as in our technology platform area.
If we start with Alzheimer's disease. Our most
Q2 2019 BioArctic AB Earnings Call Transcript
Jul 11, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers